duloxetine hydrochloride has been researched along with Urinary Bladder, Overactive in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Ariman, A; Çulha, MG; Merder, E | 1 |
| Kociszewski, J; Poleszak, E; Serefko, A; Szopa, A; Wiśniewski, R; Woźniak, A; Wróbel, A | 1 |
| Anvari, SO; Daneshpajooh, A; Dozchizadeh, S; Mirzaei, M; Teimorian, M | 1 |
| Rechberger, E; Rechberger, T; Wróbel, A | 1 |
| de Groat, WC; Matsuta, Y; Roppolo, JR; Schwen, Z; Shen, B; Tai, C; Wang, J | 1 |
| de Groat, WC; Matsuta, Y; Reese, J; Roppolo, JR; Schwen, Z; Shen, B; Tai, C; Wang, J; Xiao, Z | 1 |
| Basu, M; Duckett, JR | 2 |
| Cardozo, L; Robinson, D | 1 |
| Basu, M; Duckett, J; Vella, M | 1 |
| Goepel, M; Kirschner-Hermanns, R; Rübben, H; Steinwachs, KC; Welz-Barth, A | 1 |
| Cardozo, L; Cartwright, R; Robinson, D; Vella, M | 1 |
| Basu, M; Duckett, JR; Kavalakuntla, G; Vella, M | 1 |
| Bump, RC; Herschorn, S; Kreder, KJ; Moore, K; Steers, WD; Strohbehn, K; Yalcin, I | 1 |
4 review(s) available for duloxetine hydrochloride and Urinary Bladder, Overactive
| Article | Year |
|---|---|
Update on duloxetine for the management of stress urinary incontinence.
Topics: Depression; Duloxetine Hydrochloride; Female; Humans; Nervous System; Selective Serotonin Reuptake Inhibitors; Thiophenes; United Kingdom; Urinary Bladder, Overactive; Urinary Incontinence, Stress; Urinary Tract | 2009 |
New drug treatments for urinary incontinence.
Topics: Antidepressive Agents; Antidiuretic Agents; Antimutagenic Agents; Duloxetine Hydrochloride; Estrogens; Female; Humans; Practice Guidelines as Topic; Thiophenes; Urinary Bladder, Overactive; Urinary Incontinence | 2010 |
Urinary incontinence in the elderly: part 3 of a series of articles on incontinence.
Topics: Age Factors; Aged; Aged, 80 and over; Cholinergic Antagonists; Combined Modality Therapy; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Drug Interactions; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors; Thiophenes; Urinary Bladder, Overactive; Urinary Incontinence; Urinary Incontinence, Stress; Urinary Incontinence, Urge | 2010 |
New developments in the treatment of urinary incontinence.
Topics: Administration, Cutaneous; Adrenergic Uptake Inhibitors; Benzofurans; Drug Therapy, Combination; Duloxetine Hydrochloride; Humans; Mandelic Acids; Muscarinic Antagonists; Pyrrolidines; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Thiophenes; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Stress | 2006 |
2 trial(s) available for duloxetine hydrochloride and Urinary Bladder, Overactive
| Article | Year |
|---|---|
Evaluation of the Clinical Efficacy and Complications of Duloxetine in Comparison to Solifenacin in the Treatment of Overactive Bladder Disease in Women: A Randomized Clinical Trial.
Topics: Duloxetine Hydrochloride; Female; Humans; Muscarinic Antagonists; Solifenacin Succinate; Treatment Outcome; Urinary Bladder, Overactive | 2021 |
Duloxetine compared with placebo for treating women with symptoms of overactive bladder.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Analysis of Variance; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Middle Aged; Thiophenes; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urodynamics | 2007 |
8 other study(ies) available for duloxetine hydrochloride and Urinary Bladder, Overactive
| Article | Year |
|---|---|
The effect of Mirabegron and Duloxetine combination in mixed-type urinary incontinence treatment.
Topics: Acetanilides; Double-Blind Method; Duloxetine Hydrochloride; Humans; Retrospective Studies; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence | 2021 |
Duloxetine reverses the symptoms of overactive bladder co-existing with depression via the central pathways.
Topics: Acetanilides; Animals; Antidepressive Agents; Behavior, Animal; Corticosterone; Depression; Disease Models, Animal; Duloxetine Hydrochloride; Female; Locomotion; Rats; Rats, Wistar; Signal Transduction; Solifenacin Succinate; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents | 2020 |
The influence of duloxetine on detrusor overactivity in rats with depression induced by 13-cis-retinoic acid.
Topics: Animals; Antidepressive Agents; Depression; Duloxetine Hydrochloride; Female; Isotretinoin; Motor Activity; Rats; Rats, Sprague-Dawley; Rats, Wistar; Urinary Bladder, Overactive; Urodynamics | 2018 |
Inhibition of bladder overactivity by duloxetine in combination with foot stimulation or WAY-100635 treatment in cats.
Topics: Animals; Cats; Combined Modality Therapy; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Duloxetine Hydrochloride; Electric Stimulation Therapy; Female; Foot; Male; Piperazines; Pyridines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Thiophenes; Urinary Bladder; Urinary Bladder, Overactive | 2013 |
Effects of duloxetine and WAY100635 on pudendal inhibition of bladder overactivity in cats.
Topics: Acetic Acid; Adrenergic Uptake Inhibitors; Animals; Cats; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duloxetine Hydrochloride; Electric Stimulation; Female; Male; Piperazines; Pudendal Nerve; Pyridines; Serotonin; Serotonin Antagonists; Thiophenes; Urinary Bladder, Overactive | 2014 |
The predictive value of pre-treatment cystometry in the outcome of women with mixed incontinence treated with duloxetine.
Topics: Adult; Aged; Aged, 80 and over; Duloxetine Hydrochloride; Female; Humans; Middle Aged; Predictive Value of Tests; Quality of Life; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Thiophenes; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urodynamics | 2010 |
Tolerability and efficacy of duloxetine in a nontrial situation.
Topics: Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Humans; Middle Aged; Patient Satisfaction; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Stress; Withholding Treatment | 2007 |
Detrusor overactivity successfully treated with duloxetine.
Topics: Adrenergic Uptake Inhibitors; Duloxetine Hydrochloride; Female; Humans; Middle Aged; Thiophenes; Urinary Bladder, Overactive | 2007 |